Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade

Journal of Lipid Research

Volumn 41, Issue 1, 2000, Pages 99-108

  Kotzka, Jörg ^a   Müller Wieland, Dirk ^a   Roth, Gunther ^a   Kremer, Lorena ^a   Munck, Martina ^a   Schürmann, Sandra ^a   Knebel, Birgit ^a   Krone, Wilhelm ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Growth factors; Insulin; MAP kinase cascade; SREBPs; Transcription factors

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; WORTMANNIN;

ARTICLE; CELL STRAIN HEPG2; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION;

BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INSULIN; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); RECEPTORS, LDL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 0343851602     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hobbs, H., M. S. Brown, and J. L. Goldstein. 1992. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutal. 1: 445-466.
2. Soutar, A. K. 1998. Update on low density lipoprotein receptor mutations. Curr. Opin. Lipidol. 9: 141-147.
3. The Scandinavian Simvastatin Survival Study Group. 1994. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian simvastatin survival study (4S). Lancet. 344: 1383-1389.
4. Sachs, F. N., N. A. Pfeffer, A. M. Lemuel, J. L. Rouleau, J. D. Rutherford, T. G. Cole, L. Brown, J. W. Vranica, J. M. O. Arnold, C. Wun, B. R. Davis, and E. Braunwald. 1996. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N. Engl. J. Med. 335: 1001-1009.
5. Members of the LIPID Study Group. 1998. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N. Engl. J. Med. 339: 1349-1357.
6. Shepherd, J., S. M. Cobblin, I. Ford, C. G. Isles, A. R. Lorimer. P. W. MacFarlane, J. H. McKillop, and C. J. Peckard. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333: 1301-1307.
7. Downs, J. R., M. Clearfield, S. Weis, E. Whitney, D. R. Shapiro, P. A. Beere, A. Langendorfer, E. A. Stein, W. Kruyer, and A. M. Gotto, Jr. 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AF-CAPS/TexCAPS. Air Force/Texas coronary atherosclerosis prevention study. J. Am. Med. Assoc. 279: 1615-1622.
8. Brown, M. S., and J. L. Goldstein. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89: 331-340.
9. Sakai, J., A. Nohturfft, J. L. Goldstein, and M. S. Brown. 1998. Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies. J. Biol. Chem. 273: 5785-5793.
10. Vallet, M. M., H. B. Sanchez, J. M. Rosenfeld, and T. F. Osborne. 1996. A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutary coenzyme A reductase gene. J. Biol. Chem. 271: 12247-12253.
11. Yokoyama, C., X. Wang, M. R. Brigg, W. Admon, J. Wu, X. Hua, J. L. Goldstein, and M. S. Brown. 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 75: 187-197.
12. Spear, D. H., J. Ericsson, S. M. Jackson, and P. A. Edwards. 1994. Identification of a 6-base pair element involved in the sterol-mediated transcriptional regulation of farnesyl diphosphate synthase. J. Biol. Chem. 269: 25212-25218.
13. Jackson, S. M., J. Ericsson, J. E. Metherall, and P. A. Edwards. 1996. Role for sterol regulatory element binding protein in the regulation of farnesyl diphosphate synthase and in the control of cellular levels of cholesterol and triglyceride: evidence from sterol regulation-defecitive cells. J. Lipid Res. 37: 1712-1721.
14. Lopez, J. M., N. K. Bennett, H. B. Sanchez, J. M. Rosenfeld, and T. F. Osborne. 1996. Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc. Natl. Acad. Sci. USA. 93: 1049-1053.
15. Bennett, M. K., J. M. Lopez, H. B. Sanchez, and T. F. Osborne. 1995. Sterol regulation of fatty acid synthase promoter. J. Biol. Chem. 270: 25578-25583.
16. Ericsson, J., S. M. Jackson, J. B. Kim, B. M. Spiegelman, and P. A. Edwards. 1997. Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1-and sterol regulatory element-binding protein-responsive gene. J. Biol. Chem. 272: 7298-7305.
17. Tabor, D. E., J. B. Kim, B. M. Spiegelman, and P. A. Edwards. 1998. Transcriptional activation of the stearoyl-CoA desaturase 2 gene by sterol regulatory element-binding protein/adipocyte detemination and differentiation factor 1. J. Biol. Chem. 273: 22052-22058.
18. Sato, R., J. Inoue, Y. Kawabe, T. Kodama, T. Takano, and M. Maeda. 1996. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J. Biol. Chem. 272: 26461-26464.
19. Streicher, R., J. Kotzka, D. Müller-Wieland, G. Siemeister, M. Munck, H. Avci, and W. Krone. 1996. SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-1. J. Biol. Chem. 271: 7128-7133.
20. Basheeruddin, K., X. Li, C. Rechtoris, and T. Mazzone. 1995. Platelet-derived growth factor enhances Sp1 binding to the LDL receptor gene. Arterioscler. Thromb. Vasc. Biol. 15: 1248-1254.
21. Hua, X., J. Wu, J. L., Goldstein, M. S. Brown, and H. H. Hobbs. 1995. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 7p11.2 and 22q13. Genomics. 25: 667-673.
22. Hua, X., C. Yokoyama, J. Wu, M. R. Briggs, M. S. Brown, J. L. Goldstein, and X. Wang. 1993. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc. Natl. Acad. Sci. USA. 90: 11603-11607.
23. Chait, A., E. L. Bierman, and J. J. Albers. 1979. Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation. J. Clin. Invest. 64: 1309-1319.
24. Krone, W., H. Naegele, B. Behnke, and H. Greten. 1988. Opposite effects of insulin and catecholamines on LDL-receptor activity in human mononuclear leukocytes. Diabetes. 37: 1386-1391.
25. Mazzone, T., D. Foster, and A. Chait. 1984. In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes. 33: 333-338.
26. Wade, D. P., B. L. Knight, and A. K. Soutar. 1988. Hormonal regulation of low density lipoprotehi (LDL) receptor activity in human hepatoma Hep G2 cells. Insulin increases LDL receptor activity and deminishes its suppression by exogenous LDL. Eur. J. Biochem. 174: 213-218.
27. Pap, M., and G. M. Cooper. 1998. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 273: 19929-19932.
28. Franke, T. E., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81: 727-736.
29. Mendez, R., M. G. Myers, Jr., W. F. White, and R. K. Rhodes. 1996. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-1 phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol. Cell Biol. 16: 2857-2864.
30. Vojtek, A. B., and C. J. Der. 1998. Increasing complexity of the Ras signaling pathway. J. Biol. Chem. 273: 19925-19928.
31. Davis, R. J. 1995. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42: 459-467.
32. Yang, S. H., P. R. Yates, A. J. Whitmarsh, R. J. Davis, and A. D. Sharrocks. 1998. The Elk-1 ETS-domain transription factor contains a mitogen-activated protein kinase targeting motif. Mol. Cell Biol. 18: 710-720.
33. Hu, E., J. B. Kim, P. Sarraf, and B. M. Spiegelman. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science. 20: 2100-2103.
34. Elion, E. A. 1998. Routing MAP kinase cascades. Science. 281: 1625-1626.
35. MAPK in interleukin-1β- and tumor necrosis factor-α-induced low density lipoprotein receptor expression in HepG2 cells. J. Biol. Chem. 273: 15742-15748.
36. Davies, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268: 14553-14556.